Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
MARKERT, James M, CODY, James J, CARTNER, Samuel C, YANCEY GILLESPIE, G, WHITLEY, Richard J, PARKER, Jacqueline N, COLEMAN, Jennifer M, PRICE, Kathleen H, KERN, Earl R, QUENELLE, Debra C, LAKEMAN, Alfred D, SCHOEB, Trenton R, PALMER, Cheryl A
Published in Journal of Virology (01.05.2012)
Published in Journal of Virology (01.05.2012)
Get full text
Journal Article
Serial Passage through Human Glioma Xenografts Selects for a Δγ134.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors
SHAH, Amish C, PRICE, Kathleen H, PARKER, Jacqueline N, SAMUEL, Sharon L, MELETH, Sreelatha, CASSADY, Kevin A, GILLESPIE, G. Yancey, WHITLEY, Richard J, MARKERT, James M
Published in Journal of Virology (01.08.2006)
Published in Journal of Virology (01.08.2006)
Get full text
Journal Article
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates
Roth, Justin C, Cassady, Kevin A, Cody, James J, Parker, Jackie N, Price, Kathleen H, Coleman, Jennifer M, Peggins, James O, Noker, Patricia E, Powers, Nicholas W, Grimes, Sheila D, Carroll, Steven L, Gillespie, G Yancey, Whitley, Richard J, Markert, James M
Published in Human gene therapy. Clinical development (01.03.2014)
Published in Human gene therapy. Clinical development (01.03.2014)
Get more information
Journal Article
Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates
Roth, Justin Charles, Cassady, Kevin A, Cody, James J, Parker, Jackie N, Price, Kathleen H, Coleman, Jennifer M, Peggins, James O, Noker, Patricia E, Powers, Nicholas, Grimes, Sheila, Carroll, Steven L, Gillespie, G Yancey, Whitley, Richard, Markert, James
Published in Human gene therapy. Clinical development (28.02.2014)
Published in Human gene therapy. Clinical development (28.02.2014)
Get more information
Journal Article
Serial Passage through Human Glioma Xenografts Selects for a Delta gamma sub(1)34.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors
Shah, Amish C, Price, Kathleen H, Parker, Jacqueline N, Samuel, Sharon L, Meleth, Sreelatha, Cassady, Kevin A, Yancey Gillespie, G, Whitley, Richard J, Markert, James M
Published in Journal of virology (01.08.2006)
Get full text
Published in Journal of virology (01.08.2006)
Journal Article
Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors
Shah, Amish C, Price, Kathleen H, Parker, Jacqueline N, Samuel, Sharon L, Meleth, Sreelatha, Cassady, Kevin A, Gillespie, G Yancey, Whitley, Richard J, Markert, James M
Published in Journal of virology (01.08.2006)
Get full text
Published in Journal of virology (01.08.2006)
Journal Article
Serial Passage through Human Glioma Xenografts Selects for a Δγ 1 34.5 Herpes Simplex Virus Type 1 Mutant That Exhibits Decreased Neurotoxicity and Prolongs Survival of Mice with Experimental Brain Tumors
Shah, Amish C., Price, Kathleen H., Parker, Jacqueline N., Samuel, Sharon L., Meleth, Sreelatha, Cassady, Kevin A., Yancey Gillespie, G., Whitley, Richard J., Markert, James M.
Published in Journal of virology (01.08.2006)
Published in Journal of virology (01.08.2006)
Get full text
Journal Article